These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 804369)

  • 1. Drug metabolism in normal children, lead-poisoned children, and normal adults.
    Alvares AP; Kapelner S; Sassa S; Kappas A
    Clin Pharmacol Ther; 1975 Feb; 17(2):179-83. PubMed ID: 804369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead intoxication among demolition workers: the effect of lead on the hepatic cytochrome P-450 system in humans.
    Fischbein A; Alvares AP; Anderson KE; Sassa S; Kappas A
    J Toxicol Environ Health; 1977 Oct; 3(3):431-7. PubMed ID: 411946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of human drug metabolism by oral contraceptive steroids.
    O'Malley K; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1972; 13(4):552-7. PubMed ID: 5042369
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation.
    Meredith PA; Campbell BC; Moore MR; Goldberg A
    Eur J Clin Pharmacol; 1977 Nov; 12(3):235-9. PubMed ID: 412677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral contraceptives on plasma clearance.
    Carter DE; Bressler R; Hughes MR; Haussler MR; Christian D; Heine MW
    Clin Pharmacol Ther; 1975 Dec; 18(6):700-7. PubMed ID: 173489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haem biosynthesis and hydroxylation of phenazone during lead intoxication.
    Campbell BC; Meredith PA; Moore MR; Brodie MJ; Thompson GG; Goldberg A
    Biochem Soc Trans; 1976; 4(6):1088-9. PubMed ID: 1022564
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatomedin activity before and after chelation therapy in lead-intoxicated children.
    Rohn RD; Shelton JE; Hill JR
    Arch Environ Health; 1982; 37(6):369-73. PubMed ID: 6817717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual differences in the plasma half-lives of lipid soluble drugs in man.
    Davies DS; Thorgeirsson SS
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():181-90. PubMed ID: 5316400
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation therapy in children with subclinical plumbism.
    Chisolm JJ
    Pediatrics; 1974 Mar; 53(3):441-3. PubMed ID: 4205583
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrin clearance in homozygous beta-thalassemia.
    Rifkind AB; Canale V; New MI
    Clin Pharmacol Ther; 1976 Oct; 20(4):476-83. PubMed ID: 975719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination kinetics of blood lead in workers with chronic lead intoxication.
    Hryhorczuk DO; Rabinowitz MB; Hessl SM; Hoffman D; Hogan MM; Mallin K; Finch H; Orris P; Berman E
    Am J Ind Med; 1985; 8(1):33-42. PubMed ID: 3927718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of antipyrine in malnourished children.
    Narang RK; Mehta S; Mathur VS
    Am J Clin Nutr; 1977 Dec; 30(12):1979-82. PubMed ID: 412413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.